Search

everythinglearnresearchcommunity

for

Search:↓

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Entospletinib effectively prevents eye and skin GVHD in mice.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Trichloroethylene causes skin inflammation in mice by increasing certain immune proteins.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Alopecia areata involves specific immune cells, offering potential treatment targets.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

A man with skin and hair symptoms improved partially with specific treatment.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Researchers created a rat model to study skin damage caused by radiation, which could help develop new treatments.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Nivolumab can cause hair loss as a rare side effect.

Lichen planopilaris and frontal fibrosing alopecia are likely distinct diseases with different tissue involvement.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.